Literature DB >> 1353307

Renal receptors for atrial and C-type natriuretic peptides in the rat.

J Brown1, Z Zuo.   

Abstract

Receptors for alpha-atrial natriuretic peptide (alpha-ANP) and C-type natriuretic peptide [CNP-(1-22)] were quantified in kidneys from adult Wistar rats by in vitro autoradiography. 125I-labeled alpha-ANP (100 pM) bound reversibly to glomeruli, outer medullary vasa recta, and inner medulla with an apparent dissociation constant (Kd) of 3-6 nM. The presence of 10 microM des-[Gln18,Ser19,Gly20,Leu21,Gly22]ANP-(4- 23) (C-ANP), a specific ligand of the ANPR-C subtype of alpha-ANP receptor, inhibited approximately 50% of the glomerular binding of 125I-alpha-ANP, and this moiety of glomerular binding was also inhibited by CNP-(1-22) with an apparent inhibitory constant (Ki) of 10.47 +/- 7.59 nM. C-ANP and CNP-(1-22) showed little affinity for the medullary binding sites of alpha-ANP. 125I-[Tyr0]CNP-(1-22) (110 pM) bound solely to glomeruli and was competitively displaced by increasing concentrations of [Tyr0]CNP-(1-22) with an apparent Kd of 1.42 +/- 0.48 nM. Binding of increasing concentrations (25 pM to 1 nM) of 125I-[Tyr0]CNP-(1-22) in the presence or absence of 1 microM [Tyr0]CNP-(1-22) also demonstrated a high affinity (Kd of 0.41 +/- 0.07 nM) for the glomerular binding of 125I-[Tyr0]CNP-(1-22). Bound 125I-[Tyr0]CNP-(1-22) could be displaced by excess alpha-ANP and excess CNP-(1-22), both with high affinities. The glomerular binding of 125I-[Tyr0]CNP-(1-22) was also prevented by 10 microM C-ANP. Guanosine 3',5'-cyclic monophosphate produced by isolated glomeruli was measured by radioimmunoassay.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1353307     DOI: 10.1152/ajprenal.1992.263.1.F89

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  4 in total

Review 1.  Designer natriuretic peptides.

Authors:  D G Gardner
Journal:  J Clin Invest       Date:  1993-10       Impact factor: 14.808

2.  Vasonatrin peptide: a unique synthetic natriuretic and vasorelaxing peptide.

Authors:  C M Wei; C H Kim; V M Miller; J C Burnett
Journal:  J Clin Invest       Date:  1993-10       Impact factor: 14.808

3.  Identification of renal natriuretic peptide receptor subpopulations by use of the non-peptide antagonist, HS-142-1.

Authors:  R A Rutherford; Y Matsuda; M R Wilkins; J M Polak; J Wharton
Journal:  Br J Pharmacol       Date:  1994-11       Impact factor: 8.739

4.  Regulation of Dopamine Uptake by Vasoactive Peptides in the Kidney.

Authors:  N L Rukavina Mikusic; N M Kouyoumdzian; E Rouvier; M M Gironacci; J E Toblli; B E Fernández; M R Choi
Journal:  Scientifica (Cairo)       Date:  2016-08-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.